Ledger.Open graph →
SEC Form D · filed February 22, 2021

Excision BioTherapeutics Inc

Offering
$63.8M
Sold
$60.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

William Carson · San Francisco, CADirectorAshok Krishnamurthi · San Francisco, CADirectorVasudev Bailey · San Francisco, CADirectorDaniel Dornbusch · San Francisco, CAExec · DirectorWilliam Brady · Natick, MADirectorDaniel Nocera · Natick, MADirectorJ. Paul Austin · Natick, MADirectorHarrison Yoon · Natick, MAExec · DirectorMichael D. Baker · Newark, NJDirectorKristen A. Rivers · Larchmont, NYDirectorRyan D. Smith · Larchmont, NYDirectorPeter Treadway · Larchmont, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗